Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial
DiscussionBoTN is designed to assess the efficacy and safety of subcutaneous botulinum toxin type A injections in addition to standard prophylactic treatment in therapy-refractory trigeminal neuralgia.Trial registration numberEU Clinical Trials Register: EudraCT-No: 2014-001959-24 https://www.clinicaltrialsregister.eu/ctr-search/rest/download/trial/2014-001959-24/DEDate of trial registration26 August 2014
Source: Trials - Category: Journals (General) Authors: Jan BurmeisterDagny HolleEva BockClaudia OseHans-Christoph DienerMark Obermann Source Type: research
More News: Botox | Clinical Trials | General Medicine | Headache | Migraine | Neurology | Neurosurgery | Pain | Study